Diabetic Macular Edema Market
Diabetic Macular Edema Market Global Industry Assessment & Forecast
#
Pages:
145
2021
Nov - 2021
VMR-2021-0525
Segments Covered
By
Indication Type, diffuse diabetic macular edema, focal diabetic macular edema
-
By
Treatment Type anti-VEGF, corticosteroids, laser photocoagulation therapy, other off-label drugs
-
By
End User hospitals, clinics, home care
Snapshot
 Forecast
Years:
|
2021 - 2028 |
 Historical
Years:
|
2016 - 2020 |
 Revenue
2021: |
3.7 Billion |
 Revenue 2028:
|
4.74 Billion |
 Revenue CAGR
(2021 - 2028): |
3.15 |
Fastest Growing Region (2022 -
2028)
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Diabetic Macular Edema Market - Global Market Assessment, 2021 - 2028
The global Diabetic Macular Edema market research study is based on a comprehensive research methodology that involves 3 major activities: Secondary Research, Primary Research, and Data Triangulation. Secondary resources are utilized to gain insights on the market and later primary research is conducted to revalidate the information and conclusion derived from the secondary research. Moreover, the information procured from the secondary and primary resources is undergone through data triangulation methods to attain more accurate results on quantitative and qualitative analysis for specific market research studies.
Secondary Research
Primary Research:
The later stage covers data validation and collection from primary research. The information gained/procured from the secondary data sources is validated through extensive primary interviews with industry experts across the Diabetic Macular Edema supply chain. The primary research is also conducted to identify key players in the market and to gather and validate already procured information pertaining to their market-specific financial information. Moreover, primary research is used to gain/validate information about:
- Diabetic Macular Edema market size at regional and country level
- Key industry players and their market share and Diabetic Macular Edema market-specific sales/revenue
- Understanding of the Diabetic Macular Edema supply chain and overall ecosystem
Data Triangulation and Market Size Estimations
After arriving at the global market numbers, top-down and bottom-up approaches are used to estimate, validate and finalize the market size of the Diabetic Macular Edema market. After the determination of the overall market size, the market is divided into various segments and sub-segments. Moreover, these same approaches mentioned above were used to derive and estimate market numbers for mentioned segments/sub-segments in the market. During the data triangulation process, the data was analyzed by employing various data models and statistical techniques to arrive at exact statistics and market size for each segment/sub-segment of the market. The data is analyzed and triangulated by considering all the key market impacting factors from both supply and demand side of Diabetic Macular Edema market.
FAQ
Frequently Asked Question
What is the global demand for Diabetic Macular Edema in terms of revenue?
-
The global Diabetic Macular Edema valued at 3.7 Billion in 2020 and is expected to reach 4.74 Billion in 2028 growing at a CAGR of 3.15%.
Which are the prominent players in the market?
-
The prominent players in the market are Pfizer Inc., Bayer AG, Bausch & Lomb Incorporated, Allergan Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., ShahidBeheshti University of Medical Sciences., Johns Hopkins University, Novartis AG, The National Eye Institute..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 3.15% between 2021 and 2028.
What are the driving factors fueling the growth of the market?
-
The driving factors of the Diabetic Macular Edema include
- The increasing research & development activities for the treatment of diabetic macular edema is likely to accelerate the growth of the diabetic macular edema treatment market during the forecast period.
- Additionally, advancements in ophthalmic surgery techniques and R&D investment by pharmaceutical companies is further expected to boost the growth of the market in the years to come.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Diabetic Macular Edema in 2020.
